Ginkgo Bioworks Holdings, Inc. financial data

Symbol
DNA, DNA-WT on NYSE
Industry
Biological Products, (No Diagnostic Substances)
Location
27 Drydock Avenue, 8 Th Floor, Boston, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Soaring Eagle Acquisition Corp. (to 9/17/2021), Spinning Eagle Acquisition Corp. (to 1/4/2021)
Latest financial report
Q1 2024 - May 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 642 % -31.3%
Quick Ratio 0.44 % -90.5%
Debt-to-equity 33.5 % -28.8%
Return On Equity -65.4 % +50.5%
Return On Assets -42.5 % +57.3%
Operating Margin -396 % +11.7%

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 2.03 B shares +5.16%
Entity Public Float 2.43 B USD +1.71%
Common Stock, Value, Issued 202 K USD +4.12%
Weighted Average Number of Shares Outstanding, Basic 2 B shares +4.67%
Weighted Average Number of Shares Outstanding, Diluted 2.01 B shares +4.63%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 209 M USD -46.5%
Research and Development Expense 554 M USD -37.8%
General and Administrative Expense 344 M USD -77.7%
Operating Income (Loss) -827 M USD +52.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -854 M USD +50.7%
Income Tax Expense (Benefit) -122 K USD +99.2%
Net Income (Loss) Attributable to Parent -893 M USD +57.6%
Earnings Per Share, Basic -0.43 USD/shares +56.6%
Earnings Per Share, Diluted -0.43 USD/shares +56.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 840 M USD -30.3%
Accounts Receivable, after Allowance for Credit Loss, Current 24.2 M USD -70.9%
Inventory, Net 46 K USD -98.9%
Other Assets, Current 362 K USD -25.7%
Assets, Current 903 M USD -32%
Property, Plant and Equipment, Net 196 M USD -37.6%
Operating Lease, Right-of-Use Asset 221 M USD -43.1%
Intangible Assets, Net (Excluding Goodwill) 77.4 M USD -28.8%
Goodwill 47.9 M USD -18.4%
Other Assets, Noncurrent 60.6 M USD -37.7%
Assets 1.58 B USD -34.6%
Accounts Payable, Current 27 M USD +25.1%
Employee-related Liabilities, Current 15.7 M USD -19.4%
Accrued Liabilities, Current 115 M USD +22.9%
Contract with Customer, Liability, Current 33.6 M USD
Liabilities, Current 169 M USD -11.8%
Contract with Customer, Liability, Noncurrent 166 M USD
Operating Lease, Liability, Noncurrent 234 M USD -42%
Other Liabilities, Noncurrent 24.9 M USD -15.2%
Liabilities 594 M USD -26.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.55 M USD +3.9%
Retained Earnings (Accumulated Deficit) -5.46 B USD -18.6%
Stockholders' Equity Attributable to Parent 1.74 B USD +15.3%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 987 M USD -38.6%
Liabilities and Equity 1.58 B USD -34.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -89.3 M USD +1.46%
Net Cash Provided by (Used in) Financing Activities -845 K USD +4.84%
Net Cash Provided by (Used in) Investing Activities -12.1 M USD +37.6%
Common Stock, Shares Authorized 15.8 B shares 0%
Common Stock, Shares, Issued 2.17 B shares +4.77%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -102 M USD +7.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 887 M USD -29.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 83 K USD -9.78%
Deferred Tax Assets, Valuation Allowance 712 M USD -14.6%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 772 M USD -19.9%
Operating Lease, Liability 241 M USD -45.5%
Depreciation 54.8 M USD +48.5%
Payments to Acquire Property, Plant, and Equipment 6.71 M USD -65.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -854 M USD +50.3%
Lessee, Operating Lease, Liability, to be Paid 431 M USD -35.2%
Property, Plant and Equipment, Gross 326 M USD -22.6%
Operating Lease, Liability, Current 18.9 M USD -32.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 45.2 M USD -27.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 43.6 M USD -25%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure -12.3%
Deferred Income Tax Expense (Benefit) -801 K USD +94.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 190 M USD -14.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 39.4 M USD -36.8%
Deferred Tax Assets, Operating Loss Carryforwards 278 M USD -36%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) 0 USD
Current Income Tax Expense (Benefit) 813 K USD +89.1%
Preferred Stock, Shares Authorized 200 M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 39.4 M USD -31.3%
Operating Lease, Payments 44.1 M USD +224%
Additional Paid in Capital 6.45 B USD +3.76%
Current State and Local Tax Expense (Benefit) 690 K USD +155%
Amortization of Intangible Assets 14.8 M USD +55.8%
Deferred Tax Assets, Net of Valuation Allowance 60.4 M USD -53.8%
Share-based Payment Arrangement, Expense 198 M USD -85.4%
Deferred State and Local Income Tax Expense (Benefit) 0 USD
Interest Expense 93 K USD -12.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%